HIV Tat acts on endogenous retroviruses of the W family and this occurs via Toll-like receptor 4: Inference for neuroAIDS

AIDS

Volumn 28, Issue 18, 2014, Pages 2659-2670

  Uleri, Elena ^a   Mei, Alessandra ^a   Mameli, Giuseppe ^a   Poddighe, Luciana ^a   Serra, Caterina ^a   Dolei, Antonina ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Astrocytes; Human endogenous retrovirus w msrv syncytin 1; Monocyte macrophages; Neuroaids; Tat; Toll like receptor 4; Tumour necrosis factor alpha

Indexed keywords

CD16 ANTIGEN; CHEMOKINE RECEPTOR CCR2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; SYNCYTIN 1; TOLL LIKE RECEPTOR 4; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS PROTEIN; PLACENTA PROTEIN; SYNCYTIN; TLR4 PROTEIN, HUMAN; VIRUS ENVELOPE PROTEIN;

ARTICLE; ASTROCYTE; ENDOGENOUS RETROVIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; INTERNALIZATION; MACROPHAGE; MONOCYTE; NERVE DEGENERATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TIME; VIRUS ACTIVATION; WESTERN BLOTTING; CELL CULTURE; GENETIC TRANSCRIPTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HIV ASSOCIATED DEMENTIA; METABOLISM; MONONUCLEAR CELL; PATHOLOGY; VIROLOGY;

AIDS DEMENTIA COMPLEX; ASTROCYTES; CELLS, CULTURED; ENDOGENOUS RETROVIRUSES; GENE PRODUCTS, ENV; HIV; HUMANS; LEUKOCYTES, MONONUCLEAR; PREGNANCY PROTEINS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION, GENETIC;

EID: 84927911262     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000477     Document Type: Article

References (65)

1. Shapshak P, Kangueane P, Fujimura RK, Commins D, Chiappelli F, Singer E, et al. Editorial neuroAIDS review. AIDS 2011; 25:123-141.
2. Spudich S. HIV and neurocognitive dysfunction. Curr HIV/AIDS Rep 2013; 10:235-243.
3. Williams DW, Calderon TM, Lopez L, Carvallo-Torres L, Gaskill PJ, Eugenin EA, et al. Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14RCD16R monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis. PLoS One 2013; 8:e69270.
4. Davis LE, Hjelle BL, Miller VE, Palmer DL, Llewellyn AL, Merlin TL, et al. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 1992; 42:1736- 1739.
5. Valcour V, Chalermchai T, Sailasuta N, Marovich M, Lerdlum S, Suttichom D, et al. Central nervous system viral invasion and inflammation during acute HIV infection. J Infect Dis 2012; 206:275-282.
6. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986; 233:1089-1093.
7. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A 1986; 83:7089-7093.
8. Pulliam L, Gascon R, Stubblebine M, McGuire D, McGrath MS. Unique monocyte subset in patients with AIDS dementia. Lancet 1997; 349:692-695.
9. Thieblemont N, Weiss L, Sadeghi HM, Estcourt C. Haeffner- Cavaillon N CD14lowCD16high: A cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur J Immunol 1995; 25:3418-3424.
10. Churchill M, Nath A. Where does HIV hide? A focus on the central nervous system. Curr Opin HIV AIDS 2013; 8:165- 169.
11. Geffin R, McCarthy M. Innate immune responses to HIV infection in the central nervous system. Immunol Res 2013; 57:292-302.
12. Hudson L, Liu J, Nath A, Jones M, Raghavan R, Narayan O, et al. Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J Neurovirol 2000; 6:145-155.
13. Narasipura SD, Kim S, Al-Harthi L, Silvestri G. Epigenetic regulation of HIV-1 latency in astrocytes. J Virol 2014; 88:3031-3038.
14. Desplats P, Dumaop W, Smith D, Adame A, Everall I, Letendre S, et al. Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology 2013; 80:1415- 1423.
15. Orlando B, Giacomelli L, Chiappelli F, Barkhordarian A. New tools for the investigations of Neuro-AIDS at a molecular level: The potential role of data-mining. Bioinformation 2013; 9:656- 658.
16. Xia J, Xiong H. Neuropathogenesis of HIV-1-associated neurocognitive disorders: A possible involvement of D-serine. Int J Physiol Pathophysiol Pharmacol 2013; 5:137-147.
17. Zhou L, Saksena NK. HIV associated neurocognitive disorders. Infect Dis Rep 2013; 5:s1e8.
18. Van Lint C, Bouchat S, Marcello A. HIV-1 transcription and latency: An update. Retrovirology 2013; 10:67.
19. Irish BP, Khan ZK, Jain P, Nonnemacher MR, Pirrone V, Rahman S, et al. Molecular mechanisms of neurodegenerative diseases induced by human retroviruses: A review. Am J Infect Dis 2009; 5:231-258.
20. Li W, Li G, Steiner J, Nath A. Role of Tat protein in HIV neuropathogenesis. Neurotox Res 2009; 16:205-220.
21. Kannangai R, Sachithanandham J, Mahadevan A, Abraham AM, Sridharan G, Desai A, et al. Association of neurotropic viruses in HIV-infected individuals who died of secondary complications of tuberculosis, cryptococcosis, or toxoplasmosis in South India. J Clin Microbiol 2013; 51:1022-1025.
22. Broccolo F, Iuliano R, Careddu AM, Trovato R, Lico S, Blanc PL, et al. Detection of lymphotropic herpesvirus DNA by polymerase chain reaction in cerebrospinal fluid of AIDS patients with neurological disease. Acta Virol 2000; 44:137- 143.
23. Li L, Deng X, Linsuwanon P, Bangsberg D, Bwana MB, Hunt P, et al. AIDS alters the commensal plasma virome. J Virol 2013; 87:10912-10915.
24. Dolei A, Perron H. The multiple sclerosis-associated retrovirus and its HERV-W endogenous family: A biological interface between virology, genetics, and immunology in human physiology and disease. J Neurovirol 2009; 1:4-13.
25. Dolei A. Endogenous retroviruses and human disease. Exp Rev Clin Immunol 2006; 2:149-167.
26. Volkman HE, Stetson DB. The enemy within: endogenous retroelements and autoimmune disease. Nat Immunol 2014; 15:415-422.
27. Belshaw R, Katzourakis A, Paces J, Burt A, Tristem M. High copy number in human endogenous retrovirus families is associated with copying mechanisms in addition to reinfection. Mol Biol Evol 2005; 22:814-817.
28. Antony JM, Van Marle G, Opii W, Butterfield DA, Mallet F, Yong VW, et al. Human endogenous retrovirus glycoproteinmediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat Neurosci 2004; 7:1088- 1095.
29. Sotgiu S, Mameli G, Serra C, Zarbo IR, Arru G, Dolei A. Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis. Mult Scler 2010; 16:1248-1251.
30. Perron H, Dougier-Reynaud HL, Lomparski C, Popa I, Firouzi R, Bertrand JB, et al. Human endogenous retrovirus protein activates innate immunity and promotes experimental allergic encephalomyelitis in mice. PLoS One 2013; 8:e80128.
31. Mi S, Lee X, Li X, Veldman GM, Finnerty H, Racie L, et al. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 2000; 403:785- 789.
32. van der Kuyl AC. HIV infection and HERV expression: A review. Retrovirology 2012; 9:6.
33. Johnston JB, Silva C, Holden J, Warren KG, Clark AW, Power C. Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases. Ann Neurol 2001; 50:434-442.
34. Stevens RW, Baltch AL, Smith RP, McCreedy BJ, Michelsen PB, Bopp LH, et al. Antibody to human endogenous retrovirus peptide in urine of human immunodeficiency virus type 1- positive patients. Clin Diagn Lab Immunol 1999; 6:783-786.
35. Contreras-Galindo R, Almodóvar-Camacho S, González- Ramírez S, Lorenzo E, Yamamura Y. Comparative longitudinal studies of HERV-K and HIV-1 RNA titers in HIV-1-infected patients receiving successful versus unsuccessful highly active antiretroviral therapy. AIDS Res Hum Retroviruses 2007; 23:1083-1086.
36. Löwer R, Löwer J, Kurth R. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci U S A 1996; 93: 5177-5184.
37. Michaud HA, de Mulder M, Sengupta D, Deeks SG, Martin JN, Pilcher CD, et al. Trans-activation, posttranscriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection. Retrovirology 2014; 11:10.
38. Contreras-Galindo R, López P, Vélez R, Yamamura Y. HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro. AIDS Res Hum Retroviruses 2007; 23:116-122.
39. Gonzalez-Hernandez MJ, Swanson MD, Contreras-Galindo R, Cookinham S, King SR, Noel RJ Jr, et al. Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1. J Virol 2012; 86:7790-7805.
40. Contreras-Galindo R, Kaplan MH, Leissner P, Verjat T, Ferlenghi I, Bagnoli F, et al. Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer. J Virol 2008; 82:9329-9336.
41. Esqueda D, Xu F, Moore Y, Yang Z, Huang G, Lennon PA, et al. Lack of correlation between HERV-K expression and HIV-1 viral load in plasma specimens. Ann Clin Lab Sci 2013; 43:122- 125.
42. Arru G, Leoni S, Pugliatti M, Mei A, Serra C, Delogu LG, et al. Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: A longitudinal cohort study. Mult Scler 2014; 20:174-182.
43. Dolei A, Serra C, Mameli G, Pugliatti M, Sechi S, Cirotto MC, et al. Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients. Neurology 2002; 58:471-473.
44. Eugenin EA, Berman JW. Cytochrome C dysregulation induced by HIV infection of astrocytes results in bystander apoptosis of uninfected astrocytes by an IP(3)and calcium-dependent mechanism. J Neurochem 2013; 127:644-651.
45. Mameli G, Poddighe L, Astone V, Delogu G, Arru G, Sotgiu S, et al. Novel reliable real-time PCR for differential detection of MSRVenv and syncytin-1 in RNA and DNA from patients with multiple sclerosis. J Virol Methods 2009; 161:98-106.
46. Mameli G, Serra C, Astone V, Castellazzi M, Poddighe L, Fainardi E, et al. Inhibition of multiple-sclerosis-associated retrovirus as biomarker of interferon therapy. J Neurovirol 2008; 1:73-77.
47. Mameli G, Poddighe L, Mei A, Uleri E, Sotgiu S, Serra C, et al. Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis. PLoS One 2012; 7:e44991.
48. Serra C, Biolchini A, Mei A, Kotenko S, Dolei A. Type III and I interferons increase HIV uptake and replication in human cells that overexpress CD4, CCR5, and CXCR4. AIDS Res Hum Retroviruses 2008; 24:173-180.
49. Faber DR, Kalkhoven E, Westerink J, Bouwman JJ, Monajemi HM, Visseren FL. Conditioned media from (pre)adipocytes stimulate fibrinogen and PAI-1 production by HepG2 hepatoma cells. Nutr Diabetes 2012; 2:e52.
50. Eisenberg E, Levanon EY. Human housekeeping genes, revisited. Trends Genet 2013; 29:569-574.
51. Mameli G, Madeddu G, Mei A, Uleri E, Poddighe L, Delogu LG, et al. Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: The missing link with multiple sclerosis? PLoS One 2013; 8:e78474.
52. Mameli G, Astone V, Khalili K, Serra C, Sawaya BE, Dolei A. Regulation of the syncytin-1 promoter in human astrocytes by multiple sclerosis-related cytokines. Virology 2007; 362:120- 130.
53. Uleri E, Beltrami S, Gordon J, Dolei A, Sariyer IK. Extinction of tumor antigen expression by SF2/ASF in JCV-transformed cells. Genes Cancer 2011; 2:728-736.
54. Brudek T, Christensen T, Aagaard L, Petersen T, Hansen HJ, Møller-Larsen A. B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity. Retrovirology 2009; 6:104.
55. Ben Haij N, Leghmari K, Planès R, Thieblemont N, Bahraoui E. HIV-1 Tat protein binds to TLR4-MD2 and signals to induce TNF-a and IL-10. Retrovirology 2013; 10:123.
56. Lehnardt S, Lachance C, Patrizi S, Lefebvre S, Follett PL, Jensen FE, et al. The toll-like receptor TLR4 is necessary for lipopolysaccharide- induced oligodendrocyte injury in the CNS. J Neurosci 2002; 22:2478-2486.
57. Serra C, Mameli G, Arru G, Sotgiu S, Rosati G, Dolei A. In vitro modulation of the multiple sclerosis (MS)-associated retrovirus by cytokines: implications for MS pathogenesis. J Neurovirol 2003; 9:637-643.
58. Antony JM, Ellestad KK, Hammond R, Imaizumi K, Mallet F, Warren KG, et al. The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis: A role for endoplasmic reticulum chaperones in astrocytes. J Immunol 2007; 179:1210-1224.
59. Bagashev A, Sawaya BE. Roles and functions of HIV-1 Tat protein in the CNS: An overview. Virol J 2013; 10:358.
60. Debaisieux S, Rayne F, Yezid H, Beaumelle B. The ins and outs of HIV-1 Tat. Traffic 2012; 13:355-363.
61. Tyagi M, Rusnati M, Presta M, Giacca M. Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem 2001; 276:3254-3261.
62. Verma AS, Singh UP, Dwivedi PD, Singh A. Contribution of CNS cells in NeuroAIDS. J Pharm Bioallied Sci 2010; 2:300-306.
63. Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 2007; 13:460-469.
64. Trotta T, Porro C, Calvello R, Panaro MA. Biological role of Tolllike receptor-4 in the brain. J Neuroimmunol 2014; 268:1-12.
65. Miljković D, Timotijević G, Mostarica Stojković M. Astrocytes in the tempest of multiple sclerosis. FEBS Lett 2011; 585:3781- 3788.